[Management of osteoporosis in patients with inhaled glucocorticoids].
Clin Calcium
; 16(11): 1871-77, 2006 Nov.
Article
en Ja
| MEDLINE
| ID: mdl-17079855
ABSTRACT
Inhaled glucocorticoids are the standard of therapy in asthma and are commonly prescribed for chronic obstructive pulmonary disease. Accumulating evidence suggests that the effect of inhaled glucocorticoids on bone is not small, especially in patients taking moderate or high doses for long periods of time. The risk of adverse events is likely to differ between inhaled glucocorticoids. Inhaled glucocorticoids should be used widely, since they reduce the need of oral corticosteroids and improve respiratory function, but that they need to be managed carefully to minimize the risk of fracture with long-term use. This article described the effects of inhaled glucocorticoids on bone and fracture risk.
Buscar en Google
Bases de datos:
MEDLINE
Asunto principal:
Osteoporosis
/
Fracturas Óseas
/
Glucocorticoides
Tipo de estudio:
Etiology_studies
/
Risk_factors_studies
Límite:
Humans
Idioma:
Ja
Revista:
Clin Calcium
Asunto de la revista:
METABOLISMO
Año:
2006
Tipo del documento:
Article